Algenuity develops green solution for pharma with algae platform
Algenuity has launched the MERIT project to develop renewable methods of producing therapeutic agents.
Archives for August 7, 2018
Regeneron takes $100m stake in bluebird, with ‘long-view’ on drug discovery
Regeneron and bluebird bio have announced a partnership to develop six cell therapy drug candidates.
Science Exchange collaborates with AUM Biotech for time-saving R&D tech
Science Exchange announces a collaboration with Philadelphia start-up, AUM Biotech, to provide users with access to R&D technologies.
PepVax creates 'Trojan Horse' drug delivery platform
PepVax has developed SMARTmid, a “Trojan Horse” drug delivery platform for DNA and RNA based treatments.
NIAID enrolling patients for first-in-human trial to treat Ebola
The National Institute of Allergy and Infectious Diseases is enrolling volunteers for a first-in-human experimental treatment trial for its mAb to treat the Ebola virus.